Research Paper Volume 12, Issue 9 pp 8640—8651
Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models
Figure 4. Re-activation of NF-κB promotes cardiomyocyte damage. (A–C) qPCR assay for ATF6, IRE1 and PERK transcription in the presence of BA to activate NF-κB. (D) ELISA assay for caspase-12 activity. (E, F) Immunofluorescence staining for CHOP. *P<0.05.